Professor Anneke Lucassen, University of Oxford, on the challenge of an effective balance between predictive and diagnostic needs.

Synthetic data – artificial data that closely mimic the properties and relationships of real data – are not a new concept but technological advances have led to great optimism about their potential ...

Pharmacogenomics, a branch of precision medicine, is the study of genomic characteristics that affect how individuals respond to drugs. It could be useful for improving treatment for a wide variety of ...

Decision makers will want to realise the potential of AI for genomic medicine by speeding up delivery whilst minimising harms. We outline seven practical policy actions to help achieve this goal.

We consider the ethical, regulatory and governance implications of emerging genomic technologies. Read our assessments of the impact of reform on the implementation of new health technologies and ...

A patient arriving in A&E or another clinical setting, with suspected or known infection and the risk of sepsis, requires immediate action. Antibiotic admission more than one hour after suspected ...

The sepsis definition describes three elements: infection, the host response and life-threatening organ dysfunction. Diagnosis is made based on myriad signs and symptoms, and although infection ...

Sepsis is a critical global healthcare challenge, marked by complex and rapidly evolving symptoms, which can escalate with alarming speed leading to multi-organ failure. This leaves only a narrow ...

Cost-utility studies provide critical information for the costs and benefits of using any new test, typically building on existing public health and screening programmes, within a defined population.

The Wellcome Trust recently announced that they are funding a research programme to investigate synthetic human genomes, and Laura Blackburn, PHG Foundation’s Head of Science, had the opportunity to ...